CANADA - Canadian health officials recently said that in the recent data, reported cases of rare heart inflammation were relatively higher after Moderna's COVID-19 vaccine compared with the Pfizer/BioNTech shots. The data also indicated that heart inflammation occurs more often in individuals under 30 and in males.
The Public Health Agency of Canada's statement said most affected individuals experienced relatively mild illness and recovered quickly.
According to the statement, the risk of cardiac complications, including heart inflammation, has substantially increased following COVID-19 infections, with risks higher after the illness than after vaccination.
However, according to the World Health Organization and regulators in the United States, EU, the benefits of mRNA shots in preventing COVID-19 continue to outweigh the risks.
